Jun Liu

Dr. Jun Liu

Otolaryngology, Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in eClinicalMedicine
Verified
Journal Article
Open access
WWWenlun Wang
Wenlun Wang
HLHui Liang
Hui Liang
ZZZhouyi Zhang
Zhouyi Zhang
CXChenyang Xu
Chenyang Xu
DWDongmin Wei
Dongmin Wei
DLdapeng lei
dapeng lei
The occult lymph node metastasis (LNM) of laryngeal squamous cell carcinoma (LSCC) affects the treatment and prognosis of patients. This study aimed to comprehensively compare the performance of the three-dimensional and two-dimensional deep learning models, radiomics model, and the fusion models for predicting occult LNM in LSCC. In this retrospective diagnostic study, a total of 553 patients with clinical N0 stage LSCC, who underwent surgical treatment without distant metastasis and multiple primary cancers, were consecutively enrolled from four Chinese medical centres between January 01, 2016 and December 30, 2020. The participant data were manually retrieved from medical records, imaging databases, and pathology reports. The study cohort was divided into a training set (n = 300), an internal test set (n = 89), and two external test sets (n = 120 and 44, respectively). The three-dimensional deep learning (3D DL), two-dimensional deep learning (2D DL), and radiomics model were developed using CT images of the primary tumor. The clinical model was constructed based on clinical and radiological features. Two fusion strategies were utilized to develop the fusion model: the feature-based DLRad_FB model and the decision-based DLRad_DB model. The discriminative ability and correlation of 3D DL, 2D DL and radiomics features were analysed comprehensively. The performances of the predictive models were evaluated based on the pathological diagnosis. The 3D DL features had superior discriminative ability and lower internal redundancy compared to 2D DL and radiomics features. The DLRad_DB model achieved the highest AUC (0.89–0.90) among all the study sets, significantly outperforming the clinical model (AUC = 0.73–0.78, P = 0.0001–0.042, Delong test). Compared to the DLRad_DB model, the AUC values for the DLRad_FB, 3D DL, 2D DL, and radiomics models were 0.82–0.84 (P = 0.025–0.46), 0.86–0.89 (P = 0.75–0.97), 0.83–0.86 (P = 0.029–0.66), and 0.79–0.82 (P = 0.0072–0.10), respectively in the study sets. Additionally, the DLRad_DB model exhibited the best sensitivity (82–88%) and specificity (79–85%) in the test sets. The decision-based fusion model DLRad_DB, which combines 3D DL, 2D DL, radiomics, and clinical data, can be utilized to predict occult LNM in LSCC. This has the potential to minimize unnecessary lymph node dissection and prophylactic radiotherapy in patients with cN0 disease. 10.13039/501100001809 National Natural Science Foundation of China , 10.13039/501100007129 Natural Science Foundation of Shandong Province .

1 August 2023 in Nano Research
Verified
Journal Article
Closed access
PDF file
MYMeng Yue
Meng Yue
XHXun He
Xun He
SSShengjun Sun
Shengjun Sun
YSYuntong Sun
Yuntong Sun
Hamdy AhmedHamdy Ahmed
Hamdy Ahmed
Xuping SunXuping Sun
Xuping Sun
Developing efficient and durable oxygen evolution reaction (OER) catalysts holds great promise for green hydrogen production via seawater electrolysis, but remains a challenge. Herein, we report a Co-doped Ni3S2 nanosheet array on Ni foam (Co-Ni3S2/NF) as a high-efficiency OER electrocatalyst for seawater. In alkaline conditions, Co-Ni3S2/NF requires an overpotential of only 368 mV to drive 100 mA·cm−2, superior to Ni3S2/NF (385 mV). Besides, it exhibits at least 50-h continuous electrolysis.

5 July 2024 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
ZJZheng Jiang
Zheng Jiang
MAMailudan Ainiwaer
Mailudan Ainiwaer
Jun LiuJun Liu
Jun Liu
BYBinwu Ying
Binwu Ying
FLFengming Luo
Fengming Luo
Xuping SunXuping Sun
Xuping Sun
Hydrogen therapy, leveraging its selective attenuation of hydroxyl radicals (˙OH) and ONOO−, has emerged as a pivotal pathophysiological modulator with antioxidant, anti-inflammatory, and antiapoptotic attributes. Hydrogen therapy has been extensively studied both preclinically and clinically, especially in diseases with an inflammatory nature. Despite the substantial progress, challenges persist in achieving high hydrogen concentrations in target lesions, especially in cancer treatment. A notable breakthrough lies in water/acid reactive materials, offering enhanced hydrogen generation and sustained release potential. However, limitations include hydrogen termination upon material depletion and reduced bioavailability at targeted lesions. To overcome these challenges, catalytic materials like photocatalytic and sonocatalytic materials have surfaced as promising solutions. With enhanced permeability and retention effects, these materials exhibit targeted delivery and sustained stimuli-reactive hydrogen release. The future of hydrogen therapy hinges on continuous exploration and modification of catalytic materials. Researchers are urged to prioritize improved catalytic efficiency, enhanced lesion targeting effects, and heightened biosafety and biocompatibility in future development.

1 July 2017 in Journal of Voice
Verified
Journal Article
Closed access
DLDan Lu
Dan Lu
BWBei Wen
Bei Wen
HYHui Yang
Hui Yang
FCFei Chen
Fei Chen
Jun LiuJun Liu
Jun Liu
HWHaiyang Wang
Haiyang Wang

25 August 2021 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
HLHao Liu
Hao Liu
Jun LiuJun Liu
Jun Liu
ZLZhenhao Liu
Zhenhao Liu
QWQi Wang
Qi Wang
JLJunqiang Liu
Junqiang Liu
JZJun Zou
Jun Zou

21 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XYXue-Min Yu
Xue-Min Yu
YLYing Liu
Ying Liu
TJTong Jin
Tong Jin
Jun LiuJun Liu
Jun Liu
JWJuan Wang
Juan Wang
XPXin-Liang Pan
Xin-Liang Pan
Sirtuin 1 (SIRT1) plays an important role in tumorigenesis and is increased in many human tumors. DBC1 is a negative regulator of SIRT1 via promotion of p53-mediated apoptosis. It is necessary to investigate the expression of SIRT1 and DBC1 in laryngeal and hypopharyngeal squamous cell carcinomas (LSCC and HSCC) and its correlation with available clinical parameters. The mRNA levels of SIRT1 and DBC1 were measured in 54 paired LSCC or HSCC tumors and corresponding adjacent noncancerous mucosae using quantitative RT-PCR (qRT-PCR). The protein levels of SIRT1 and DBC1 were also evaluated in 120 cases of patients with LSCC or HSCC using immunohistochemical staining. The correlation between SIRT1 and DBC1 expression and clinical parameters was analyzed with Pearson chi-square test. qRT-PCR assay showed that, compared with the paired adjacent noncancerous mucosae, SIRT1 mRNA was significantly decreased in tumors. The immunohistochemical results indicated that the SIRT1 protein was also downregulated in tumors compared with noncancerous mucosae. Moreover, decreased SIRT1 was significantly correlated with the tumor clinical stage and lymph node metastasis. Additionally, DBC1 mRNA was significantly increased in tumors compared with noncancerous mucosae. The immunohistochemical results indicated that the DBC1 protein was downregulated in tumors, which is inconsistent with the results obtained by qRT-PCR. Finally, decreased DBC1 protein was significantly correlated with tumor differentiation, lymph node metastasis, and p53 expression. SIRT1 and DBC1 might be involved in the pathophysiology of laryngeal and hypopharyngeal squamous cell carcinomas and are associated with lymph node metastasis and p53 positive staining in LSCCs and HSCCs.